Infection Control and Hospital Epidemiology最新文献

Objective and design: Therapies provided in nontraditional settings or by individuals without knowledge of core principles of infection prevention and control (IPC) may place consumers at risk of adverse events. We summarize findings from our recent consultation experiences in the Division of Healthcare Quality Promotion (DHQP) at the Centers for Disease Control and Prevention (CDC) to help identify targets for prevention efforts and enhanced consumer protections.

Methods: We reviewed records of DHQP consultations with state, local, or territorial health officials conducted from 2016 to 2023 to identify investigations involving nontraditional therapies or settings in the United States. Information collected included type of procedure or therapy, type of setting, pathogens involved, number of affected individuals, and types of IPC issues identified.

Results: Of 1500 consultations, we identified 30 (2%) involving nontraditional therapies or settings. Therapies were performed for esthetic reasons, general wellness, or as treatment for pain. Infectious pathogens were identified in the blood, joint fluid, and skin and soft tissue, and included viruses, bacteria, and fungi. Investigations revealed breaches in injection safety, medical device reprocessing, medication preparation and handling, and environmental disinfection. Over 7000 consumers received notification regarding potential exposure to an infectious pathogen.

Conclusions: This summary highlights the potential infectious risks to consumers posed by nontraditional therapies, which may have unproven benefits and poorly defined risks. With continued expansion of nontraditional therapies and settings, consumers will benefit from education, training, and oversight of those who provide therapies in these settings.

The publication rate of abstracts presented at a conference can provide some insight into its academic quality, although it is hardly the sole metric. We evaluated 351 SHEA Spring Conference abstracts; 49.9% were published. Findings demonstrate the strong academic output of SHEA conferences.

Background: Shorter antibiotic courses and transition to oral therapy for uncomplicated gram-negative bloodstream infections (GN-BSI) are evidence-supported yet remain challenging to implement. Here we report our experience with a GN-BSI antimicrobial stewardship (AS) quality improvement initiative in a large health system.

Methods: We implemented two sequential AS interventions in adult patients hospitalized with uncomplicated GN-BSI: (1) mandatory AS review of patients discharging on intravenous (IV) antibiotics ("OPAT review") and (2) a clinical guideline informing oral antibiotic transition and duration, in our 22-hospital system. We evaluated the initiative from January 2018 to September 2024. Pre- and postimplementation rates of (1) IV antibiotics at discharge and (2) total length of antibiotic therapy were calculated across the following periods: preintervention, after OPAT review, and after guideline implementation. Secondary outcomes included duration <10 days, oral antibiotic prescribing, and guideline-recommended dosing.

Results: 3,231 patients (preintervention: 666, postOPAT review: 1,357, postguideline: 1,208) were included. We observed decreases in IV antibiotics at discharge (22.7% preintervention, 10.7% postOPAT review, and 9.2% postguideline, p < 0.001) and median length of treatment (13.5 days preintervention to 10.7 days postguideline, p < 0.001). We also observed improvement in durations <10 days (19.1% vs 45%, p < 0.001), oral antibiotic prescriptions, and appropriate dosing (2.8% vs 33.5%, p < 0.001), but no difference in rates of BSI recurrence, mortality, or C. difficile infection.

Conclusion: After implementing GN-BSI-focused AS initiatives in our large health system, we observed a shift toward more frequent oral rather than IV antibiotics at discharge, and shorter overall antibiotic durations, without obvious changes in adverse outcomes.

We characterized antibiotic prescribing for outpatient telemedicine visits among a large cohort of pediatric, adult, and older adult populations during 2021. Opportunities exist for improving antibiotic prescribing in outpatient telemedicine, especially for respiratory conditions and among rural and older adult populations.

Objective: Assess knowledge, attitudes, and practices for control of Candidozyma auris among healthcare providers in long-term acute care hospitals (LTACHs).

Design: Mixed methods; quantitative survey, followed by qualitative focus groups.

Setting: Two LTACHs with endemic spread of C. auris in the Chicago, Illinois region.

Participants: Convenience sample of frontline healthcare providers.

Results: Fifty-three quantitative surveys were completed, and 21 individuals participated in qualitative focus groups. Survey participants were 92% female, 43% nurses, and 60% had >10 years of experience in their current role. They reported awareness of high-priority healthcare-associated multidrug-resistant pathogens, including C. auris (86%). Most participants agreed that C. auris is a national problem (74%), but only 56% agreed it was a problem in their own hospital. Barriers to C. auris prevention identified in the survey included understaffing (63%), lack of training (52%), lack of coworker accountability (48%), and lack of adequate time for task completion (49% for self, 48% for coworkers). Focus groups included 10 nurses, 5 patient care technicians, 3 secretaries, and 3 therapists. Focus groups highlighted the importance of enforcement and monitoring of prevention measures and the need for additional education. When asked how to improve infection prevention at their hospital, participants identified themes of education, improvements in enforcement and monitoring of prevention measures, staff support, and improvements in visual communication and healthcare design.

Conclusions: In this cohort of frontline LTACH healthcare providers, we identified multiple barriers to C. auris containment and elicited potential solutions. These insights suggest targets for future interventions to improve C. auris control.

Background: In the neonatal intensive care unit (NICU), outbreaks caused by methicillin-susceptible Staphylococcus aureus (MSSA) are less commonly described than outbreaks caused by methicillin-resistant Staphylococcus aureus (MRSA) despite the increased burden of MSSA infections.

Objective: To investigate a NICU MSSA outbreak utilizing whole-genome sequencing (WGS) and multi-locus sequencing typing (MLST) to identify transmission events.

Methods: An investigation was initiated in a level IV NICU after four patients developed MSSA skin and soft tissue infections (SSTI) within three weeks. MLST and WGS were performed on MSSA isolates obtained from clinical and surveillance specimens.

Results: During the outbreak, 16 infants developed MSSA infections including SSTIs (n = 15) and bacteremia (n = 1). Thirteen SSTIs presented on neonates' faces, all of whom were on non-invasive respiratory support. During 7 rounds of surveillance, an additional 31 patients were found to be colonized with MSSA. MLST identified a predominant cluster (ST-121). WGS found that all ST-121 isolates were closely related (≤10 genetic variants between isolates) suggesting likely transmission events, harbored the mupA gene, exhibited mupirocin MIC values ≥1,024 µg/mL, and were associated with infection. Multiple infection control measures were implemented including the "bare below the elbows" practice. No further mupirocin-resistant isolates were recovered or ST-121 SSTIs identified after Week 26.

Conclusions: WGS analysis furthered the MLST analysis and identified a single MLST as the outbreak-related strain. Successful control of this outbreak was achieved with a multitude of infection prevention and control methods.

Background: Outbreak investigation and control are critical for preventing the spread of infectious diseases in healthcare settings. Traditional methods rely on manual processes, which are time-consuming and limited in scope. Whole genome sequencing (WGS) surveillance improves outbreak detection but still requires extensive manual chart reviews to identify transmission routes. Integrating artificial intelligence (AI) may enhance the efficiency and accuracy of these investigations.

Methods: We evaluated an AI tool developed to streamline healthcare outbreak investigations detected by the Enhanced Detection System for Healthcare-associated Transmission (EDS-HAT). For outbreaks detected between November 2021 and November 2023, multiple data elements were extracted from electronic health records (EHR) for all patients. The AI algorithm was applied to identify transmission routes, and its performance was assessed against expert manual reviews. Key measures included additional transmission routes identified and sensitivity.

Results: Data from 172 outbreaks involving 476 case patients were analyzed. The AI tool identified 37 transmission routes that were missed by manual review, including procedures and provider routes. The algorithm achieved a sensitivity of 76.0% (95% confidence interval [CI] 71.1%-81.1%) compared to manual review, increasing to 91.7% (95% CI 87.7%-94.7%) after accounting for transmission at other facilities and downstream exposures.

Conclusion: The EDS-HAT AI tool significantly improved outbreak investigations by automating the identification of transmission routes, both with concordant findings of manual review as well as finding additional routes of transmission missed by traditional chart review. AI with genomic surveillance has the potential to optimize outbreak detection and investigation to streamline interventions in healthcare settings.

Background: Recipients of hematopoietic cell transplantation (HCT) are at increased risk for Clostridioides difficile infection (CDI) and its recurrence, which are associated with significant morbidity. We aimed to characterize risk factors for primary and recurrent CDI in a large cohort of HCT recipients.

Methods: We conducted a retrospective cohort study of 2725 adults who underwent HCT from 2010-2023 to evaluate the epidemiology, timing, and risk factors for CDI. We compared patients who developed CDI with those who did not, adjusting for patient demographics, comorbidities, transplant factors, medications, and laboratory values. Among patients who developed CDI, we investigated risk factors for recurrent CDI.

Results: The cumulative 1-year incidence of CDI was 17.8% among allogeneic HCT recipients (181/1016) and 4.1% among autologous recipients (71/1709). Overall CDI incidence increased by 1.4% annually during the study period (95%CI: 1.24-1.53%). Independent risk factors for primary CDI included penicillin antibiotics (aOR 1.51; 95%CI: 1.13-2.02), prior chemotherapy (aOR 8.36; 95%CI: 2.95-23.69 for 1-3 regimens), and umbilical cord blood stem cells (aOR 1.95; 95%CI: 1.07-3.57). Autologous HCT was associated with decreased risk. Among 252 patients with primary CDI, 22 (8.7%) developed recurrence. Macrolide use before index CDI (aOR 7.25; 95%CI: 1.80-29.2) and allogeneic HCT (aOR 31.04; 95%CI: 1.37-731.58) were associated with recurrence.

Conclusion: CDI is a common, early complication of HCT particularly among allogeneic recipients. Penicillin exposure, prior chemotherapy, and cord blood stem cell source are key risk factors, while macrolide use is associated with recurrence. Our findings highlight potential targets for risk-stratified prevention strategies.